Racine IVF Unit, Lis Maternity Hospital, Tel-Aviv Sourasky Medical Center, 6 Weizmann St., Tel-Aviv 64239, Israel.
In Vitro Cell Dev Biol Anim. 2010 Apr;46(3-4):327-36. doi: 10.1007/s11626-010-9275-5. Epub 2010 Feb 26.
Human embryonic stem cells (HESCs) carrying specific mutations potentially provide a valuable tool for studying genetic disorders in humans. One preferable approach for obtaining these cell lines is by deriving them from affected preimplantation genetically diagnosed embryos. These unique cells are especially important for modeling human genetic disorders for which there are no adequate research models. They can be further used to gain new insights into developmentally regulated events that occur during human embryo development and that are responsible for the manifestation of genetically inherited disorders. They also have great value for the exploration of new therapeutic protocols, including gene-therapy-based treatments and disease-oriented drug screening and discovery. Here, we report the establishment of 15 different mutant human embryonic stem cell lines derived from genetically affected embryos, all donated by couples undergoing preimplantation genetic diagnosis in our in vitro fertilization unit. For further information regarding access to HESC lines from our repository, for research purposes, please email dalitb@tasmc.health.gov.il.
携带特定突变的人类胚胎干细胞(HESCs)为研究人类遗传疾病提供了有价值的工具。获得这些细胞系的一种较好方法是从受影响的植入前遗传诊断胚胎中衍生而来。这些独特的细胞对于模拟没有适当研究模型的人类遗传疾病尤为重要。它们还可以进一步用于深入了解人类胚胎发育过程中发生的受发育调控的事件,这些事件是遗传疾病表现的原因。它们对于探索新的治疗方案也具有重要价值,包括基于基因治疗的治疗方法以及针对疾病的药物筛选和发现。在这里,我们报告了从我们的体外受精单位进行植入前遗传诊断的夫妇捐赠的遗传异常胚胎中建立的 15 种不同的突变人类胚胎干细胞系。如需获取我们的细胞系进行研究,请通过 dalitb@tasmc.health.gov.il 联系我们。